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LETTER TO THE EDITOR
Season of detection of breast cancer
Sir - In a recent letter Galea and Blamey (Br. J. Cancer
(1991), 63, 157) have been unable to find a difference in
either frequency of tumour detection or patient survival
associated with season of detection of breast cancer. This is
in contrast to our recent publication 'Season of initial dis-
covery of tumour as an independent variable predicting sur-
vival in breast cancer', Br. J. Cancer (1990) 61, 137-141.
It is abundantly desirable that this possible seasonal
phenomenon is sought for in breast cancer data files from
various geographic regions. It is, of course, important that
such analyses involve the month of first detection of tumour
by the patient rather than simply the month of surgery or
biopsy, since the time between these events is variable.
We acknowledged in our paper the independence and
power of the known prognostic variables in breast cancer,
particularly nodal status, tumour size, and steroid hormone
receptor status. Using proportional hazards regression
analysis the season of tumour detection remained a signi-
ficant prognostic variable when allowing for these factors,
although statistically weaker than the others. It is therefore
unlikely to exert a major influence on the results oftreatment
or prognosis if allowance is made for the major prognostic
variables.
An increase in breast tumour detection spring/summer is
now documented in seven published papers. We do acknow-
ledge however that there may be geographic regions where
the seasonal detection of tumours has not been apparent and
these findings may not have been published. If there is no
difference in season of tumour detection with regards to
incidence then it is unlikely that season of tumour detection
would influence survival in that particular group of women.
Galea and Blamey were not able to show that women
> = 50 years with oestrogen receptors in the tumour had
any difference in survival according to season of tumour
detection. It would be of interest to know whether they were
able to show a survival difference according to presence of
oestrogen receptors in this group irrespective of season. It is
noteworthy that our study included all cases over 9 years
from one geographic region, whereas it is unclear whether the
Nottingham data is a record of all cases of breast cancer in
that area. There was also no screening by mammography
during the 9 years of the collection of the Auckland data file
and this may be a further point of difference between the
patient groups. We agree with Galea and Blamey that further
reports will be necessary before this debate can be resolved.
yours etc,
Barbara Mason (Scientific Officer),
Ian Holdaway (Assoc Professor of Endocrinology),
Auckland Breast Cancer Study Group,
University of Auckland,
Auckland, New Zealand.
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